Eli Lilly and Co 2023 SR
The report highlights Lilly's progress toward its 2030 sustainability goals, including achieving a 26% reduction in absolute greenhouse gas emissions since 2020 and purchasing 28.4% of its electricity from renewable sources. The company provided $4.3 billion in free medicines to charitable organizations and reached 18 million people in resource-limited settings as part of its 30x30 goal. Socially, Lilly achieved 49% women in management globally and spent $1.5 billion with small and diverse suppliers. The report also details efforts in water stewardship, waste reduction, and clinical trial diversity.
Company: Eli Lilly and Co
Sector: Health Care
Country: United States
Year: 2023
Type: SR
Pages: 133
Eli Lilly and Co
Sustainability Report
The report highlights Lilly's progress toward its 2030 sustainability goals, including achieving a 26% reduction in absolute greenhouse gas emissions since 2020 and purchasing 28.4% of its electricity from renewable sources. The company provided $4.3 billion in free medicines to charitable organizations and reached 18 million people in resource-limited settings as part of its 30x30 goal. Socially, Lilly achieved 49% women in management globally and spent $1.5 billion with small and diverse suppliers. The report also details efforts in water stewardship, waste reduction, and clinical trial diversity.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
May 20, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees